AQR Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.02M Buy
8,880
+232
+3% +$32.4K ﹤0.01% 2764
2025
Q4
$1.42M Sell
8,648
-568
-6% -$89K ﹤0.01% 2351
2025
Q3
$1.18M Buy
+9,216
New +$1.12M ﹤0.01% 2328
2025
Q2
Sell
-2,062
Closed -$262K 3377
2025
Q1
$262K Buy
+2,062
New +$317K ﹤0.01% 2747
2023
Q3
Sell
-10,161
Closed -$1.44M 2369
2023
Q2
$1.44M Buy
+10,161
New +$1.63M ﹤0.01% 1409
2022
Q1
Sell
-6,601
Closed -$1.75M 2283
2021
Q4
$1.75M Buy
6,601
+89
+1% +$24K ﹤0.01% 1254
2021
Q3
$1.88M Sell
6,512
-4,441
-41% -$1.14M ﹤0.01% 1177
2021
Q2
$2.19M Sell
10,953
-2,237
-17% -$434K ﹤0.01% 1172
2021
Q1
$2.54M Sell
13,190
-1,202
-8% -$246K ﹤0.01% 1090
2020
Q4
$2.72M Buy
14,392
+5,290
+58% +$962K ﹤0.01% 1013
2020
Q3
$1.34M Sell
9,102
-64,802
-88% -$9.26M ﹤0.01% 1274
2020
Q2
$9.04M Sell
73,904
-15,342
-17% -$1.8M 0.01% 654
2020
Q1
$8.62M Sell
89,246
-21,438
-19% -$2.07M 0.01% 659
2019
Q4
$10.2M Sell
110,684
-31,463
-22% -$2.64M 0.01% 745
2019
Q3
$10.9M Buy
142,147
+7,599
+6% +$665K 0.01% 743
2019
Q2
$11.6M Buy
134,548
+17,892
+15% +$1.22M 0.01% 736
2019
Q1
$6.89M Buy
116,656
+17,836
+18% +$1.03M 0.01% 886
2018
Q4
$5.21M Buy
98,820
+18,806
+24% +$1.1M 0.01% 933
2018
Q3
$4.44M Sell
80,014
-6,023
-7% -$310K ﹤0.01% 1056
2018
Q2
$4.05M Sell
86,037
-59,270
-41% -$2.44M ﹤0.01% 1122
2018
Q1
$5.26M Sell
145,307
-44,500
-23% -$1.56M 0.01% 981
2017
Q4
$6.89M Buy
189,807
+31,962
+20% +$1.16M 0.01% 910
2017
Q3
$6.05M Buy
157,845
+84,457
+115% +$3.54M 0.01% 949
2017
Q2
$3.04M Buy
73,388
+35,500
+94% +$1.35M ﹤0.01% 1222
2017
Q1
$1.33M Sell
37,888
-8,424
-18% -$267K ﹤0.01% 1558
2016
Q4
$1.43M Sell
46,312
-21,331
-32% -$660K ﹤0.01% 1570
2016
Q3
$2.04M Buy
67,643
+13,382
+25% +$404K ﹤0.01% 1407
2016
Q2
$1.49M Sell
54,261
-928
-2% -$23.7K ﹤0.01% 1447
2016
Q1
$1.48M Buy
55,189
+34,692
+169% +$849K ﹤0.01% 1411
2015
Q4
$580K Sell
20,497
-51,824
-72% -$1.49M ﹤0.01% 1812
2015
Q3
$2.01M Sell
72,321
-23,590
-25% -$852K ﹤0.01% 1128
2015
Q2
$3.96M Sell
95,911
-42,326
-31% -$1.55M 0.01% 916
2015
Q1
$4.2M Sell
138,237
-63,505
-31% -$1.65M 0.01% 844
2014
Q4
$4M Sell
201,742
-85,383
-30% -$1.91M 0.01% 996
2014
Q3
$5.72M Sell
287,125
-90,200
-24% -$1.9M 0.02% 772
2014
Q2
$8.6M Sell
377,325
-55,700
-13% -$992K 0.02% 689
2014
Q1
$5.57M Buy
433,025
+125,800
+41% +$1.8M 0.02% 815
2013
Q4
$4.19M Buy
307,225
+81,378
+36% +$972K 0.01% 953
2013
Q3
$2.5M Buy
+225,847
New +$2.25M 0.01% 1146

Other funds holding RGEN

AQR Capital Management's RGEN Position: Q1 2026 in Review

AQR Capital Management increased its Repligen (RGEN) stake by 2.7% in Q1 2026, buying an estimated $32.4K and bringing the position to 8,880 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2764.

AQR Capital Management first reported a position in RGEN in Q3 2013 and has held it in 39 quarters since. The position peaked at $11.6M in Q2 2019. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • AQR Capital Management held 8,880 shares of Repligen worth $1.02M as of Q1 2026.
  • AQR Capital Management bought 232 Repligen shares in Q1 2026, an estimated $32.4K.
  • Repligen made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #2764 holding.
  • AQR Capital Management first reported a position in Repligen in Q3 2013 and has held it in 39 quarters since.
  • AQR Capital Management's Repligen position peaked at $11.6M in Q2 2019.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.